Can bilirubin nanomedicine become a hope for the management of COVID-19?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can bilirubin nanomedicine become a hope for the management of COVID-19?
Authors
Keywords
COVID-19, Bilirubin, Biliverdin, Nanomedicine, Anti-inflammatory, Antioxidant
Journal
MEDICAL HYPOTHESES
Volume 149, Issue -, Pages 110534
Publisher
Elsevier BV
Online
2021-02-15
DOI
10.1016/j.mehy.2021.110534
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
- (2020) Haijun Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19
- (2020) Isabella Orienti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- and Animal Models for SARS-CoV-2 research
- (2020) Kazuo Takayama TRENDS IN PHARMACOLOGICAL SCIENCES
- Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis
- (2020) Qing Yao et al. JOURNAL OF CONTROLLED RELEASE
- Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
- (2020) Abigail Vanderheiden et al. JOURNAL OF VIROLOGY
- Dexamethasone nanomedicines for COVID-19
- (2020) Twan Lammers et al. Nature Nanotechnology
- Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation
- (2020) Libor Vítek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is hydroxychloroquine beneficial for COVID-19 patients?
- (2020) Xing Li et al. Cell Death & Disease
- Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
- (2020) Qing Yao et al. Frontiers in Pharmacology
- COVID-19 and the liver: little cause for concern
- (2020) Mansoor N Bangash et al. Lancet Gastroenterology & Hepatology
- COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
- (2020) Carlo Contini et al. Microorganisms
- A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy
- (2020) Suchithra Poilil Surendran et al. Acta Biomaterialia
- Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling
- (2020) Hyeongseop Keum et al. JOURNAL OF CONTROLLED RELEASE
- Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Alexandra Lindsey Zune Djomkam et al. Frontiers in Oncology
- Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
- (2020) Fatemeh Oroojalian et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Therapeutic application and construction of bilirubin incorporated nanoparticles
- (2020) Qing Yao et al. JOURNAL OF CONTROLLED RELEASE
- Nanoceria as a possible agent for the management of COVID-19
- (2020) Prince Allawadhi et al. Nano Today
- Therapeutic applications of selenium nanoparticles
- (2019) Amit Khurana et al. BIOMEDICINE & PHARMACOTHERAPY
- Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation
- (2019) Jia-Dong Zheng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
- (2019) Ryoko Takei et al. PLoS One
- Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia
- (2018) Ryoichi Fujiwara et al. HEPATOLOGY
- In-vivo sustained release of nanoencapsulated ferulic acid and its impact in induced diabetes
- (2018) Richa Panwar et al. Materials Science & Engineering C-Materials for Biological Applications
- Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-Responsive Drug Delivery System for Targeted Cancer Therapy
- (2018) Yonghyun Lee et al. Advanced Science
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nanomedicine: Principles, Properties, and Regulatory Issues
- (2018) Sara Soares et al. Frontiers in Chemistry
- Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
- (2016) Yonghyun Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells
- (2016) Lovro Ziberna et al. Scientific Reports
- The pharmacological features of bilirubin: the question of the century
- (2015) Farhana Zahir et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The innate immune function of airway epithelial cells in inflammatory lung disease
- (2015) Pieter S. Hiemstra et al. EUROPEAN RESPIRATORY JOURNAL
- Bilirubin Possesses Powerful Immunomodulatory Activity and Suppresses Experimental Autoimmune Encephalomyelitis
- (2014) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- Techniques for physicochemical characterization of nanomaterials
- (2013) Ping-Chang Lin et al. BIOTECHNOLOGY ADVANCES
- The molecular basis for the immunomodulatory activities of unconjugated bilirubin
- (2013) Sushrut Jangi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Nanoparticle-Sensitized Photodegradation of Bilirubin and Potential Therapeutic Application
- (2012) Soumik Sarkar et al. Journal of Physical Chemistry C
- Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro
- (2012) Rosaria Santangelo et al. Frontiers in Pharmacology
- The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular Diseases
- (2012) Libor Vítek Frontiers in Pharmacology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search